about
Screening for lung cancerScreening for lung cancerAcyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer.Lung cancer diagnosis from proteomic analysis of preinvasive lesions.MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives.Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma.MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis.High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry.Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.Molecular imaging of proteins in tissues by mass spectrometry.Advances in proteomic strategies toward the early detection of lung cancerComparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers.Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancerMALDI profiling of human lung cancer subtypes.Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants.Imaging of intact tissue sections: moving beyond the microscopeIdentification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Comprehensive identification of proteins from MALDI imaging.Evolving concepts in lung carcinogenesisLung cancer screening: history, current perspectives, and future directionsPathogenesis of lung cancer: 100 year report.Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.Update in lung cancer 2005.Type 1 diabetes: entering the proteomic era.The state of molecular biomarkers for the early detection of lung cancer.MALDI-MS derived prognostic protein markers for resected non-small cell lung cancerMass spectrometry-based proteomic profiling of lung cancer.The field of tissue injury in the lung and airway.Integrating the MicroRNome into the study of lung disease.Research status and funding trends of lung cancer biomarkers.Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer.Application of glycoproteomics for the discovery of biomarkers in lung cancer.Proteomics of lung cell biology and pulmonary disease.Diagnostic accuracy of MALDI-TOF mass spectrometry for non-small cell lung cancer: a meta-analysis.
P2860
Q24201867-C124370F-8C0B-4402-9918-5CF8E3D19619Q24247464-36D630CF-08A7-47E0-BA2F-45D64CD63E67Q30407718-F775C5DC-34E9-41E4-B011-8A1E31BBBCCDQ30468516-120D032E-11D9-41A5-A4A4-031A254D156FQ30470146-C2913DD0-EEAC-4E56-A16E-4D498E27946BQ30475550-FDB8C78F-A5A2-4EB6-BAF1-B7CCE33AA4D6Q30476935-1C87D20A-89C9-4AEE-8105-9438E23AE5FCQ30479894-F0A48710-80B6-4F10-AF93-6BF3FC932E00Q30484594-6C3C8675-C6CF-4F63-8E2F-199478F9DDB1Q30489516-359AF4AF-D4A9-4F91-BBA8-A1E75A4928DFQ31008766-84A16B87-0962-400B-8C11-F19331655B1BQ33428572-DD58BE71-2DC4-44A3-8690-6E6380D3AB2FQ33472669-73D27BEA-B28F-40E6-B996-74022DDC26B8Q33515026-AC29D075-7449-443E-9470-29077422FE2DQ33525226-F53CAD3A-B17B-41B8-A4C6-DF911724FC12Q33761618-21C321F1-C3F6-4FCD-BD53-411628631AD3Q33919463-E2F0308F-05CD-496B-8279-CD1B14645E6EQ34148738-430A479A-A60E-43A1-9168-51F1569219F4Q34350615-E7B12A5B-A4DE-4CB1-8B1B-346C9459CD79Q34778073-192A792E-748B-4C12-98C1-15951238ADD8Q36178320-7A186BF1-189A-45DA-AD3E-5A1EF5EF41F8Q36220674-D9619B3B-8968-45F1-ABBB-B8B21A664573Q36233709-03005C23-23BE-4BC0-BBF9-814D41E63CC4Q36273955-017778D5-E87B-4E50-96F3-56ECF49AAAADQ36288148-02D7EB47-1B62-4226-B011-1B1BC427688CQ36429911-6A54973F-5732-4A2E-9806-8CC36C1FC138Q36445582-A90A0CEC-AE8C-4CA9-9B59-FE6EBCC08C95Q37044593-40C45501-675D-48D2-997B-016317BE1A41Q37057878-F77374BA-4359-4233-8FFB-276775ABCD88Q37171914-277904A9-7513-4F66-81AC-F511DBB7CA59Q37250499-0E361E02-2477-4B04-B4FB-76A064CAD296Q37267032-645044B2-E59C-4795-9B83-3E30DA46A480Q37274578-2657DA58-7887-4DDD-9549-8AFC655CB7E7Q37365408-6243BA87-4A23-4830-A50F-8F20EF569DF6Q37417542-27422FF5-748C-4CFD-A024-56389FC4C647Q37660297-2E4BE525-5DDE-4D01-A540-8B62A03E35AFQ37754857-238DF586-A997-431C-88BD-C6F96191425AQ49628399-E4C70EF3-C7C0-4E52-AAB2-E225BC710EE4
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Proteomic patterns of preinvasive bronchial lesions
@ast
Proteomic patterns of preinvasive bronchial lesions
@en
type
label
Proteomic patterns of preinvasive bronchial lesions
@ast
Proteomic patterns of preinvasive bronchial lesions
@en
prefLabel
Proteomic patterns of preinvasive bronchial lesions
@ast
Proteomic patterns of preinvasive bronchial lesions
@en
P2093
P2860
P1476
Proteomic patterns of preinvasive bronchial lesions
@en
P2093
Adriana L Gonzalez
Bonnie S Slovis
David P Carbone
Huiming Li
Kiyoshi Yanagisawa
Mathew Ninan
Pierre Chaurand
Pierre P Massion
Pinar B Yildiz
Richard M Caprioli
P2860
P304
P356
10.1164/RCCM.200502-274OC
P407
P577
2005-09-22T00:00:00Z